Flamma Honkai (Dalian)

Flamma USA is located in Malvern, PA and can help with early-stage pre-clinical supply of small molecule APIs

Flamma is a premier supplier of custom made specialty Fmoc- amino acids. Please stop by to learn more

Flamma can make small peptide fragments via liquid phase synthesis. Stop by to learn more.

Flamma Spa offers minoxidil so please reach out to learn more directly via FlammaGroup.com

Flamma Spa the highest quality melatonin on the market so please reach out to learn more directly via FlammaGroup.com

Flamma Spa offers a wide range of active ingredients which includes acetyl thiazolidin carboxylic acid. Contact us for more information.

Flamma Spa offers a wide range of active pharmaceutical ingredients which includes acetyl-dl-leucine. Contact us for more information.

Flamma Spa offers a wide range of active pharmaceutical ingredients which includes acetyl-l-carnitine HCL. Contact us for more information.

Flamma Spa offers a wide range of active pharmaceutical ingredients which includes acetyl-l-glutamine. Contact us for more information.

Flamma Spa offers a wide range of active ingredients which includes acexamic acid. Contact us for more information.

Flamma Spa offers a wide range of active ingredients which includes aminexil. Contact us for more information.

Flamma Spa offers a wide range of intermediates which includes boc-cis-4-methoxy-d-proline. Alternative compound name: cis-boc-4-methoxy-d-proline. It belongs to boc-intermediates category. Contact us for more information.

The company wil acquire a third API manufacturing site in Lecco, Italy as of April this year 

FLAMMA is a CDMO with Headquarters near Milan, Italy. As a fully integrated CDMO, we can leverage our 100% self-owned, self-managed facilities, in Italy and China to deliver a stable, reliable supply chain. We specialize in the cGMP manufacturing of APIs, NCEs, RSMs, &Advanced intermediates (NCEs and generics). We use our expertise in high value chiral materials (specifically amino acid related materials) to provide solutions to customers who not only have need for chiral materials but also clients who have other requirements with a various type of chemistries. In addition, we also manufacture specialty compounds and advanced intermediates for the nutraceutical and cosmetic industries, and others.

We are approaching the end of a year which saw global vaccine rollout for COVID-19, 44 novel drug approvals (to date) and the return of the CPHI Worldwide in-person event.

Learn about Flamma in under 1 minutes by viewing this video.

The CDMO says the suite will help to "bring back manufacturing to the US"

This one page article describes the tactics being used in the CDMO industry to gain business that ultimately costs innovator companies more money and time.

A short article that features Kenneth Drew, VP Flamma USA discussing what makes Flamma different from other CDMOs.

Flamma announced the expansion of its Continuous Flow capabilities with the investment of ~$2M

FLAMMA announced the another addition to its Continuous Flow capabilities with the addition of a Corning G4 Microreactor.

FLAMMA announced the commitment to invest $200M over the next three years. This significant investment will propel Flamma forward.